Portfolio

Curis

Develops innovative therapeutics targeting cancer network disruption

  • Lexington, MA
  • NASDAQ: CRIS

  • Contact:
    Marty Sutter
  • Formerly Known As: Reprogenesis
  • Acquisition
  • Acquired by: Taseko
  • Exit date: September 08, 2014

All content © 2023
Legal Disclaimer | Privacy Notice

Powered by ITVibes